Molica S - Search Results

1

Italian real-life experience with brentuximab vedotin: results of a large observational study of 40 cases of relapsed/refractory systemic anaplastic large cell lymphoma.

Broccoli A, Pellegrini C, Di Rocco A, Puccini B, Patti C, Gini G, Mannina D, Tani M, Rusconi C, Romano A, Vanazzi A, Botto B, Carlo-Stella C, Hohaus S, Musto P, Mazza P, Molica S, Corradini P, Fama A, Gaudio F, Merli M, Gravetti A, Gritti G, Arcari A, Tosi P, Liberati AM, Pinto A, Pavone V, Gherlinzoni F, Naso V, Volpetti S, Trentin L, Goldaniga MC, Bonfichi M, De Renzo A, Schiavotto C, Spina M, Storti S, Carella AM, Stefoni V, Argnani L, Zinzani PL. Broccoli A, et al. Among authors: molica s. Haematologica. 2017 Nov;102(11):1931-1935. doi: 10.3324/haematol.2017.171355. Epub 2017 Aug 3. Haematologica. 2017. PMID: 28775121 Free PMC article.

2

Recombinant alpha-2a interferon in treatment of B-chronic lymphocytic leukemia. A preliminary report with emphasis on previously untreated patients in early stage of disease.

Molica S, Alberti A. Molica S, et al. Haematologica. 1990 Jan-Feb;75(1):75-8. Haematologica. 1990. PMID: 2338291

3

Alpha interferon in the treatment of chronic myelomonocytic leukemia.

Catalano L, Majolino I, Musto P, Fragrasso A, Molica S, Cirincione S, Selleri C, Luciano L, De Renzo A, Vecchione R, et al. Catalano L, et al. Among authors: molica s. Haematologica. 1989 Nov-Dec;74(6):577-81. Haematologica. 1989. PMID: 2628240

4

Prognostic features and therapeutical approaches in B-cell chronic lymphocytic leukemia: an update.

Molica S, De Rossi G, Luciani M, Levato D. Molica S, et al. Haematologica. 1995 Mar-Apr;80(2):176-93. Haematologica. 1995. PMID: 7628755 Review.

5

Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study.

Molica S, Musto P, Chiurazzi F, Specchia G, Brugiatelli M, Cicoira L, Levato D, Nobile F, Carotenuto M, Liso V, Rotoli B. Molica S, et al. Haematologica. 1996 Mar-Apr;81(2):121-6. Haematologica. 1996. PMID: 8641639 Clinical Trial.

6

Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.

Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S. Molica S, et al. Haematologica. 1996 Jul-Aug;81(4):302-9. Haematologica. 1996. PMID: 8870373

7

Prognosis of chronic myelomonocytic leukemia.

Catalano L, Improta S, de Laurentiis M, Molica S, Majolino I, Musto P, Fragasso A, De Placido S, Rotoli B. Catalano L, et al. Among authors: molica s. Haematologica. 1996 Jul-Aug;81(4):324-9. Haematologica. 1996. PMID: 8870376

8

Cellular expression and serum circulating levels of CD23 in B-cell chronic lymphocytic leukemia. Implications for prognosis.

Molica S, Levato D, Dell'Olio M, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P. Molica S, et al. Haematologica. 1996 Sep-Oct;81(5):428-33. Haematologica. 1996. PMID: 8952156

9

Clinico-prognostic implications of increased levels of soluble CD54 in the serum of B-cell chronic lymphocytic leukemia patients. Results of a multivariate survival analysis.

Molica S, Levato D, Dell' Olio M, Cascavilla N, Matera R, Minervini M, Dattilo A, Carotenuto M, Musto P. Molica S, et al. Haematologica. 1997 Mar-Apr;82(2):148-51. Haematologica. 1997. PMID: 9175316

10

Clinical and prognostic evaluation of bone marrow infiltration (biopsy versus aspirate) in early chronic lymphocytic leukemia. A single center study.

Molica S, Tucci L, Levato D, Docimo C. Molica S, et al. Haematologica. 1997 May-Jun;82(3):286-90. Haematologica. 1997. PMID: 9234573

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page